Enum: MaxResearchPhaseEnum

Permissible Values

Value	Meaning	Description
preclinical_research_phase	None	Biolink 'preclinical_research' is the union of both the `FDA discovery and de...
clinical_trial_phase	None	Clinical research involves trials of the drug on people, and it is one of the...
clinical_trial_phase_1	None	In the FDA Clinical Trial Phase, the Clinical Trial Phase 1 involves 20 – 100...
clinical_trial_phase_2	None	In the FDA Clinical Trial Phase, the Clinical Trial Phase 2 involves up to se...
clinical_trial_phase_3	None	In the FDA Clinical Trial Phase, the Clinical Trial Phase 3 involves 300 – 30...
clinical_trial_phase_4	None	In the FDA Clinical Trial Phase, the Clinical Trial Phase 4 involves several ...
not_provided	None

Slots

Name	Description
max_research_phase

Identifier and Mapping Information

Schema Source

from schema: https://w3id.org/biolink/biolink-model

LinkML Source

name: MaxResearchPhaseEnum
from_schema: https://w3id.org/biolink/biolink-model
permissible_values:
  preclinical_research_phase:
    text: preclinical_research_phase
    description: 'Biolink ''preclinical_research'' is the union of both the `FDA discovery
      and development phase` and  `FDA preclinical research phase`. Discovery involves
      researchers finding new possibilities for medication  through testing molecular
      compounds, noting unexpected effects from existing treatments, or the creation
      of  new technology that allows novel ways of targeting medical products to sites
      in the body. Drug development  occurs after researchers identify potential compounds
      for experiments Preclinical Research Phase.   Once researchers have examined
      the possibilities a new drug may contain, they must do preliminary research  to
      determine its potential for harm (toxicity). This is categorized as preclinical
      research and can be one of  two types: in vitro or in vivo.'
    notes:
    - DrugBank calls this 'experimental'.
  clinical_trial_phase:
    text: clinical_trial_phase
    description: Clinical research involves trials of the drug on people, and it is
      one of the most involved stages in the drug development and approval process.
      Clinical trials must answer specific questions and follow a protocol determined
      by the drug researcher or manufacturer.
  clinical_trial_phase_1:
    text: clinical_trial_phase_1
    description: In the FDA Clinical Trial Phase, the Clinical Trial Phase 1 involves
      20 – 100 study participants and lasts several months. This phase is used to
      determine the safety and dosage of the drug, and about 70% of these drugs move
      on to the next clinical research phase.
    is_a: clinical_trial_phase
  clinical_trial_phase_2:
    text: clinical_trial_phase_2
    description: In the FDA Clinical Trial Phase, the Clinical Trial Phase 2 involves
      up to several hundred people, who must have the disease or condition the drug
      supposes to treat. This phase can last from a few months to two years, and its
      purpose is to monitor the efficacy of the drug, as well as note side effects
      that may occur.
    is_a: clinical_trial_phase
  clinical_trial_phase_3:
    text: clinical_trial_phase_3
    description: In the FDA Clinical Trial Phase, the Clinical Trial Phase 3 involves
      300 – 3000 volunteers and can last up to four years. It is used to continue
      monitoring the efficacy of the drug, as well as exploring any longer-term adverse
      reactions.
    is_a: clinical_trial_phase
  clinical_trial_phase_4:
    text: clinical_trial_phase_4
    description: In the FDA Clinical Trial Phase, the Clinical Trial Phase 4 involves
      several thousands of volunteers who have the disease or condition and continues
      to monitor safety and efficacy. If a drug passes this phase, it goes on to FDA
      review.
    is_a: clinical_trial_phase
  not_provided:
    text: not_provided